Plain-English translation of NCT00869817 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer's Disease research guide →The Dominantly Inherited Alzheimer Network (DIAN) is a long-term study that tracks families who carry a genetic mutation causing early-onset Alzheimer's disease. Researchers want to understand what happens in the brain years before memory problems start—before symptoms appear. By following participants over time with regular check-ups, blood tests, and brain imaging, scientists hope to detect the earliest warning signs and eventually develop ways to prevent or delay the disease.
Inherited Alzheimer's disease, while rare, follows a predictable pattern because the genetic cause is known. By studying families who carry these mutations, researchers can learn exactly how the disease develops in the brain long before a person feels sick or forgets things. This knowledge could lead to new treatments not just for inherited Alzheimer's, but for all Alzheimer's disease.
You likely qualify if…
You likely don't qualify if…
You would join a registry and visit a research center every 2 years for assessments that include cognitive testing, blood draws, brain imaging scans, and discussions about your family health history. The study is designed to follow you over many years, with the focus on comparing people who carry the genetic mutation with those who do not. All visits follow the same standardized protocol so researchers can track changes in your brain and biomarkers over time.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States